BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 [PMID: 25170201 DOI: 10.3748/wjg.v20.i32.11142]
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11142.htm
Number Citing Articles
1
Jing Zhang, Xiongfei Xu, Min Shi, Ying Chen, Danghui Yu, Chenyan Zhao, Yan Gu, Biao Yang, Shiwei Guo, Guiling Ding, Gang Jin, Chin-Lee Wu, Minghua Zhu. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinomaOncoImmunology 2017; 6(2): e1258504 doi: 10.1080/2162402X.2016.1258504
2
Sanga Mitra, Sayak Ganguli, Jayprokas Chakrabarti. Cancer and Noncoding RNAs2018; : 1 doi: 10.1016/B978-0-12-811022-5.00001-2
3
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
4
Zhenyu Wang, Wenhao Shen, Xugang Li, Yang Feng, Kun Qian, Gaoren Wang, Yiying Gao, Xiaohui Xu, Shuyu Zhang, Ling Yue, Jianping Cao. <p>The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells</p>Drug Design, Development and Therapy 2020; : 3099 doi: 10.2147/DDDT.S242557
5
Balbina García-Reyes, Anna-Laura Kretz, Jan-Philipp Ruff, Silvia von Karstedt, Andreas Hillenbrand, Uwe Knippschild, Doris Henne-Bruns, Johannes Lemke. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2018; 19(10): 3219 doi: 10.3390/ijms19103219
6
Yanping Zhong, Jinsong Liu, Xiaoran Li, Shannon N. Westin, Anais Malpica, Barrett C. Lawson, Sanghoon Lee, Bryan M. Fellman, Robert L. Coleman, Anil K. Sood, Nicole D. Fleming. A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant ChemotherapyCancers 2021; 13(4): 704 doi: 10.3390/cancers13040704
7
Diana Behrens, Jana Rolff, Jens Hoffmann. New Approaches to Drug DiscoveryHandbook of Experimental Pharmacology 2015; 232: 203 doi: 10.1007/164_2015_29
8
Juan Gonzalez-Valdivieso, Andres Garcia-Sampedro, Andrew R. Hall, Alessandra Girotti, Francisco Javier Arias, Stephen P. Pereira, Pilar Acedo. Smart Nanoparticles as Advanced Anti-Akt Kinase Delivery Systems for Pancreatic Cancer TherapyACS Applied Materials & Interfaces 2021; 13(47): 55790 doi: 10.1021/acsami.1c14592
9
Li Wang, Jun Luo, Yuchen Li, Yanrong Lu, Yi Zhang, Bole Tian, Ziyi Zhao, Qiong-ying Hu. Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic CancerFrontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.817672
10
Shadab Md, Nabil A. Alhakamy, Hibah M. Aldawsari, Javed Ahmad, Waleed S. Alharbi, Hani Z. Asfour. Resveratrol loaded self-nanoemulsifying drug delivery system (SNEDDS) for pancreatic cancer: Formulation design, optimization and in vitro evaluationJournal of Drug Delivery Science and Technology 2021; 64: 102555 doi: 10.1016/j.jddst.2021.102555
11
Julie Leca, Sébastien Martinez, Sophie Lac, Jérémy Nigri, Véronique Secq, Marion Rubis, Christian Bressy, Arnauld Sergé, Marie-Noelle Lavaut, Nelson Dusetti, Céline Loncle, Julie Roques, Daniel Pietrasz, Corinne Bousquet, Stéphane Garcia, Samuel Granjeaud, Mehdi Ouaissi, Jean Baptiste Bachet, Christine Brun, Juan L. Iovanna, Pascale Zimmermann, Sophie Vasseur, Richard Tomasini. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressivenessJournal of Clinical Investigation 2016; 126(11): 4140 doi: 10.1172/JCI87734
12
Qingke Duan, Hehe Li, Chenggang Gao, Hengqiang Zhao, Shihong Wu, Heshui Wu, Chunyou Wang, Qiang Shen, Tao Yin. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathwayJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1209-9
13
Iera Hernandez-Unzueta, Aitor Benedicto, Irene Romayor, Alba Herrero, Eduardo Sanz, Beatriz Arteta, Elvira Olaso, Joana Márquez. Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated ChemoresistancePancreas 2019; 48(4): 555 doi: 10.1097/MPA.0000000000001277
14
Rebecca A. Richmond, Quan V. Vuong, Christopher J. Scarlett. Cytotoxic Effect of Bitter Melon (Momordica charantia L.) Ethanol Extract and Its Fractions on Pancreatic Cancer Cells in vitroExploratory Research and Hypothesis in Medicine 2017; 2(4): 1 doi: 10.14218/ERHM.2017.00032
15
Nabil A. Alhakamy, Osama A. A. Ahmed, Usama A. Fahmy, Shadab Md. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic CancerPharmaceuticals 2021; 14(8): 729 doi: 10.3390/ph14080729
16
Sonam Kumari, Mohammed Sikander, Shabnam Malik, Manish K. Tripathi, Bilal B. Hafeez, Murali M. Yallapu, Subhash C. Chauhan, Sheema Khan, Meena Jaggi. Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer CellsBiomedicines 2021; 9(12): 1814 doi: 10.3390/biomedicines9121814
17
Jair Machado Espindola-Netto, Claudia C.S. Chini, Mariana Tarragó, Enfeng Wang, Shamit Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Mauro Sola-Penna, Eduardo N. Chini. Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancerOncotarget 2017; 8(49): 85054 doi: 10.18632/oncotarget.18841
18
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment2021; : 79 doi: 10.1007/978-3-030-68334-4_6
19
Clara Angeles, Danny Lascano, Gregory Veillette. Surgical Decision Making in Geriatrics2020; : 303 doi: 10.1007/978-3-030-47963-3_24
20
Asadur Rahman, Makoto Matsuyama, Akio Ebihara, Yuki Shibayama, Arif Ul Hasan, Hironori Nakagami, Fumiaki Suzuki, Jiao Sun, Tomoe Kobayashi, Hiroki Hayashi, Daisuke Nakano, Hideki Kobara, Tsutomu Masaki, Akira Nishiyama. Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal AdenocarcinomaMolecular Cancer Therapeutics 2020; 19(9): 1844 doi: 10.1158/1535-7163.MCT-19-0228
21
Hui Zhang, Xuan Zhang, Xun Li, Wen‐Bo Meng, Zhong‐Tian Bai, Shao‐Zhen Rui, Zheng‐Feng Wang, Wen‐Ce Zhou, Xiao‐Da Jin. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancerJournal of Cellular Physiology 2019; 234(1): 619 doi: 10.1002/jcp.26816
22
Jie Wu, Zhifang Li, Yong Li, Alex Pettitt, Feifan Zhou. Photothermal Effects of Reduced Graphene Oxide on Pancreatic CancerTechnology in Cancer Research & Treatment 2018; 17: 153303461876863 doi: 10.1177/1533034618768637
23
Felipe Camelo, Anne Le. The Heterogeneity of Cancer MetabolismAdvances in Experimental Medicine and Biology 2021; 1311: 77 doi: 10.1007/978-3-030-65768-0_5
24
Diana Behrens, Wolfgang Walther, Iduna Fichtner. Pancreatic cancer models for translational researchPharmacology & Therapeutics 2017; 173: 146 doi: 10.1016/j.pharmthera.2017.02.013
25
Bo Tang, Yang Li, Guangying Qi, Shengguang Yuan, Zhenran Wang, Shuiping Yu, Bo Li, Songqing He. Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic CancerScientific Reports 2015; 5(1) doi: 10.1038/srep13563
26
Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park. Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancerGastrointestinal Endoscopy 2018; 88(6): 926 doi: 10.1016/j.gie.2018.06.024
27
Seong Joon Park, Seung-Mi Kim, Jai-Hee Moon, Jeong Hee Kim, Jae-Sik Shin, Seung-Woo Hong, Yu Jin Shin, Dae-Hee Lee, Eun Young Lee, Ih-Yeon Hwang, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Won–Keun Lee, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim. SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherinTumor Biology 2016; 37(4): 4323 doi: 10.1007/s13277-015-4216-2
28
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomicsEJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
29
Xue Li, Mingming Zhen, Meilan Yu, Chen Zhou, Lei Li, Chunying Shu, Chunru Wang, Chunli Bai. Gadofullerene nanoparticles extend survival rate and down-regulate thrombin expression in orthotopic pancreatic cancerScience China Materials 2022; 65(2): 508 doi: 10.1007/s40843-021-1761-3
30
Christy Goldsmith, Patricia Price, Timothy Cross, Sheila Loughlin, Ian Cowley, Nicholas Plowman. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose ConstraintsSeminars in Radiation Oncology 2016; 26(2): 149 doi: 10.1016/j.semradonc.2015.12.002
31
Sayan D. Gupta, Pappu S. Swapanthi, Deshetti Bhagya, Fernando Federicci, Gisela I. Mazaira, Mario D. Galigniana, Chavali V.S. Subrahmanyam, Naryanasamy L. Gowrishankar, Nulgumnalli M. Raghavendra. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing ApproachAnti-Cancer Agents in Medicinal Chemistry 2020; 20(3): 369 doi: 10.2174/1871520619666191111152050
32
Sarojamma Vemula, Manoj K. Gupta, Venkat R. Arva Tatireddygari, Ramakrishna Vadde. Theranostic Approach for Pancreatic Cancer2019; : 245 doi: 10.1016/B978-0-12-819457-7.00012-8
33
Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao, Hong Ke. RETRACTED ARTICLE: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathwaysCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0665-1
34
Kenya Kamimura, Takeshi Yokoo, Shuji Terai. Gene Therapy for Pancreatic Diseases: Current StatusInternational Journal of Molecular Sciences 2018; 19(11): 3415 doi: 10.3390/ijms19113415
35
Julia Rudno-Rudzińska, Wojciech Kielan, Maciej Guziński, Maciej Płochocki, Agnieszka Antończyk, Julita Kulbacka. New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) – A pilot preclinical studySurgical Oncology 2021; 38: 101634 doi: 10.1016/j.suronc.2021.101634
36
Lihua He, Lizhi Niu, Nikolai N. Korpan, Sajio Sumida, Yueyong Xiao, Jiaping Li, Barlian Sutedja, Youyong Lu, Jiansheng Zuo, Jianguo Liu, Kecheng Xu. Clinical Practice Guidelines for Cryosurgery of Pancreatic CancerPancreas 2017; 46(8): 967 doi: 10.1097/MPA.0000000000000878
37
Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock, Tara E. Seery, William P. Harris, Darren S. Sigal, Fadi Braiteh, Paul S. Ritch, Mark M. Zalupski, Nathan Bahary, Paul E. Oberstein, Andrea Wang-Gillam, Wilson Wu, Dimitrios Chondros, Ping Jiang, Sihem Khelifa, Jie Pu, Carrie Aldrich, Andrew E. Hendifar. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaJournal of Clinical Oncology 2018; 36(4): 359 doi: 10.1200/JCO.2017.74.9564
38
Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas, Konstantinos Mavridis. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/319861
39
Jin-Hui Zhu, Qiu-Liang Yan, Jian-Wei Wang, Yan Chen, Qing-Huang Ye, Zhi-Jiang Wang, Tao Huang. The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection MethodFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.554502
40
Qun Chen, Wu-Jun Wang, Yun-Xuan Jia, Hao Yuan, Peng-Fei Wu, Wan-Li Ge, Ling-Dong Meng, Xu-Min Huang, Peng Shen, Tao-Yue Yang, Yi Miao, Jing-Jing Zhang, Kui-Rong Jiang. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative reviewCell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00602-8
41
Andrea Marie Ibrahim, Yao-He Wang. Viro-immune therapy: A new strategy for treatment of pancreatic cancerWorld Journal of Gastroenterology 2016; 22(2): 748-763 doi: 10.3748/wjg.v22.i2.748
42
Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu, Ping Bie. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axisJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1340-7
43
Yi Yu, Jia-Tian Dong, Bing He, Yu-Feng Zou, Xue-Song Li, Chen-Hui Xi, Yuan Yu. LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancerFuture Oncology 2019; 15(33): 3831 doi: 10.2217/fon-2019-0321
44
Dehong Hu, Zhuwen Chen, Zonghai Sheng, Duyang Gao, Fei Yan, Teng Ma, Hairong Zheng, Mei Hong. A catalase-loaded hierarchical zeolite as an implantable nanocapsule for ultrasound-guided oxygen self-sufficient photodynamic therapy against pancreatic cancerNanoscale 2018; 10(36): 17283 doi: 10.1039/C8NR05548C
45
Carlotta Spano, Giulia Grisendi, Giulia Golinelli, Filippo Rossignoli, Malvina Prapa, Marco Bestagno, Olivia Candini, Tiziana Petrachi, Alessandra Recchia, Francesca Miselli, Giulia Rovesti, Giulia Orsi, Antonino Maiorana, Paola Manni, Elena Veronesi, Maria Serena Piccinno, Alba Murgia, Massimo Pinelli, Edwin M. Horwitz, Stefano Cascinu, Pierfranco Conte, Massimo Dominici. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37433-6
46
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
47
Patricia Coutinho de Souza, Ashish Ranjan, Rheal A Towner. Nanoformulations for therapy of pancreatic and liver cancersNanomedicine 2015; 10(9): 1515 doi: 10.2217/nnm.14.231
48
Yifan Duan, Xiaoyu Yin, Xiaorong Lai, Chao Liu, Wenjing Nie, Dongfeng Li, Zijun Xie, Zijun Li, Fan Meng. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer CellsTechnology in Cancer Research & Treatment 2020; 19: 153303381989549 doi: 10.1177/1533033819895494
49
Min‑Gu Lee, Kyu‑Shik Lee, Kyung‑Soo Nam. The association of changes in RAD51 and survivin expression levels with the proton beam sensitivity of Capan‑1 and Panc‑1 human pancreatic cancer cellsInternational Journal of Oncology 2018;  doi: 10.3892/ijo.2018.4642
50
YUKARI NISHII, MIKI YAMAGUCHI, YASUTOSHI KIMURA, TADASHI HASEGAWA, HIROYUKI ABURATANI, HIROAKI UCHIDA, KOICHI HIRATA, YUJI SAKUMA. A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cellsInternational Journal of Oncology 2015; 46(4): 1781 doi: 10.3892/ijo.2015.2880
51
Frank Zimmermann, Alexandros Papachristofilou, Viviane Hess, Christoph Kettelhack. Nur in seltenen Fällen besteht die Chance auf HeilungInfo Onkologie 2015; 18(5): 45 doi: 10.1007/s15004-015-0712-1
52
Xiao-Mei Luo, Li-Zhi Niu, Ji-Bing Chen, Ke-Cheng Xu. Advances in cryoablation for pancreatic cancerWorld Journal of Gastroenterology 2016; 22(2): 790-800 doi: 10.3748/wjg.v22.i2.790
53
Giulia Fontana, Marco Riboldi, Chiara Gianoli, Cezarina I. Chirvase, Gaetano Villa, Chiara Paganelli, Paul E. Summers, Barbara Tagaste, Andrea Pella, Piero Fossati, Mario Ciocca, Guido Baroni, Francesca Valvo, Roberto Orecchia. MRI quantification of pancreas motion as a function of patient setup for particle therapy -a preliminary studyJournal of Applied Clinical Medical Physics 2016; 17(5): 60 doi: 10.1120/jacmp.v17i5.6236
54
Fundamentals of Cancer Detection, Treatment, and Prevention2022; : 341 doi: 10.1002/9783527838561.ch15
55
Imaging in Gastroenterology2018; : 470 doi: 10.1016/B978-0-323-55408-4.50225-1
56
Jia-Rong Li, Ling Liu, Hui Luo, Ze-Guo Chen, Jian-Hua Wang, Nian-Feng Li. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling AxisPancreas 2021; 50(3): 317 doi: 10.1097/MPA.0000000000001751
57
Madeline T. Olson, Quan P. Ly, Aaron M. Mohs. Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and TranslationMolecular Imaging and Biology 2019; 21(2): 200 doi: 10.1007/s11307-018-1239-2
58
Ryo Ashida, Mitsuhiro Nakamura, Michio Yoshimura, Takashi Mizowaki. Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning studyJournal of Applied Clinical Medical Physics 2020; 21(7): 49 doi: 10.1002/acm2.12883
59
Giorgia Mandili, Claudia Curcio, Sara Bulfamante, Laura Follia, Giulio Ferrero, Emanuela Mazza, Moitza Principe, Francesca Cordero, Maria Antonietta Satolli, Rosella Spadi, Andrea Evangelista, Daniele Giordano, Duy Viet, Paola Cappello, Francesco Novelli. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccinationJournal for ImmunoTherapy of Cancer 2020; 8(2): e001071 doi: 10.1136/jitc-2020-001071
60
E. A. Bykova, N. A. Falaleeva, L. Yu. Grivtsova. PANCREATIC CANCER, CURRENT THERAPEUTIC APPROACHES AND POSSIBLE PROSPECTSRussian Journal of Biotherapy 2020; 19(4): 18 doi: 10.17650/1726-9784-2020-19-4-18-28
61
Lusine Demirkhanyan, Christopher S. Gondi. Clinical Applications of Non-Coding RNAs in Cancer2022; : 1 doi: 10.1016/B978-0-12-824550-7.00011-4
62
Yun-Fei Liu, Dong Luo, Xia Li, Zhi-Qiang Li, Xiao Yu, Hong-Wei Zhu. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic CancerPancreas 2021; 50(2): 227 doi: 10.1097/MPA.0000000000001747
63
Manu Gnanamony, Christopher S. Gondi. Chemoresistance in pancreatic cancer: Emerging conceptsOncology Letters 2017; 13(4): 2507 doi: 10.3892/ol.2017.5777
64
Diagnostic Imaging: Gastrointestinal2015; : 1034 doi: 10.1016/B978-0-323-37755-3.50289-0
65
Tao Wang, Radhika Narayanaswamy, Huilan Ren, James W. Gillespie, Valery A. Petrenko, Vladimir P. Torchilin. Phage-derived protein-mediated targeted chemotherapy of pancreatic cancerJournal of Drug Targeting 2018; 26(5-6): 505 doi: 10.1080/1061186X.2017.1405424
66
Qing-Guo Liu, Yan-Ju Li, Lan Yao. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axisPancreatology 2018; 18(6): 678 doi: 10.1016/j.pan.2018.07.003
67
Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith, Rajesh Agarwal. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumorsMolecular Carcinogenesis 2020; 59(10): 1227 doi: 10.1002/mc.23251
68
Xingxing Li, Jingyun Li, Bin Zhang, Yuqing Gu, Qian Li, Guangliang Gu, Jiageng Xiong, Yanan Li, Xiaojun Yang, Zhuyin Qian. Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancerThe International Journal of Biochemistry & Cell Biology 2020; 120: 105687 doi: 10.1016/j.biocel.2020.105687
69
Claudia C.S. Chini, Jair M. Espindola-Netto, Gourish Mondal, Anatilde M. Gonzalez Guerrico, Veronica Nin, Carlos Escande, Mauro Sola-Penna, Jin-San Zhang, Daniel D. Billadeau, Eduardo N. Chini. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent PathwayClinical Cancer Research 2016; 22(10): 2496 doi: 10.1158/1078-0432.CCR-15-1760
70
Julia Benzel, Volker Fendrich. Familial Pancreatic CancerOncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
71
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
72
Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and TreatmentInternational Journal of Molecular Sciences 2017; 18(6): 1201 doi: 10.3390/ijms18061201
73
Min Li, Huilan Xu. Fear stress enhanced xenograft pancreatic tumor growth through activating epithelial-mesenchymal transitionPancreatology 2019; 19(2): 377 doi: 10.1016/j.pan.2019.01.002
74
Song Wang, Cecilie L. Bager, Morten A. Karsdal, Dimitrios Chondros, Darin Taverna, Nicholas Willumsen. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfaJournal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02701-z
75
Konrad Klinghammer, Wolfgang Walther, Jens Hoffmann. Choosing wisely – Preclinical test models in the era of precision medicineCancer Treatment Reviews 2017; 55: 36 doi: 10.1016/j.ctrv.2017.02.009
76
Satoshi Uchida, Hiroaki Kinoh, Takehiko Ishii, Akitsugu Matsui, Theofilus Agrios Tockary, Kaori Machitani Takeda, Hirokuni Uchida, Kensuke Osada, Keiji Itaka, Kazunori Kataoka. Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moietyBiomaterials 2016; 82: 221 doi: 10.1016/j.biomaterials.2015.12.031
77
Pan Pan, Chad Skaer, Jianhua Yu, Hui Zhao, He Ren, Kiyoko Oshima, Li-Shu Wang. Berries and other natural products in pancreatic cancer chemoprevention in human clinical trialsJournal of Berry Research 2017; 7(3): 147 doi: 10.3233/JBR-170159
78
Yongping Zhou, Ting Shan, Wenzhou Ding, Zhiyuan Hua, Yijun Shen, Zhihua Lu, Bo Chen, Tu Dai. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo‐YAP signalingJournal of Cellular Physiology 2018; 233(8): 5805 doi: 10.1002/jcp.26357
79
Felipe Camelo, Anne Le. The Heterogeneity of Cancer MetabolismAdvances in Experimental Medicine and Biology 2018; 1063: 73 doi: 10.1007/978-3-319-77736-8_5
80
Wan-Chi Tsai, Li-Yuan Bai, Yi-Jin Chen, Po-Chen Chu, Ya-Wen Hsu, Aaron M. Sargeant, Jing-Ru Weng. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signalingOncotarget 2017; 8(17): 29233 doi: 10.18632/oncotarget.16450